Dr. Lal PathLabs CEO Bharath Uppilliappan steps down
Uppilliappan joined Dr. Lal Pathlabs in 2016 as Chief Operating Officer and later became CEO
Uppilliappan joined Dr. Lal Pathlabs in 2016 as Chief Operating Officer and later became CEO
Dr Sheth's will commission a Healthmobile on Wheels initiative to ensure that healthcare doesn't remain confined to urban centers
Sadhana Nitro Chem's plant is the second plant in the world to manufacture pAP from Nitrobenzene
Acquisition of exclusive commercialization rights for European markets
The proposed hospital will have a bed capacity of 300 beds and the investment in the project is expected to be around Rs. 500 crore
Collaborative Research in AYUSH is extremely important as it bridges the gap between traditional knowledge and modern scientific research
Launch of Indian public health standards for Ayush healthcare facilities
EDQM conducts GMP inspection of SMS Pharmaceuticals’ API facility
Clinical findings support the safety and efficacy of BMND08 at a maximum dosage of 12mg
The agreement licenses the company to launch in the United States, in February 2025, once approved by the U.S. FDA
Subscribe To Our Newsletter & Stay Updated